SiTime Corporation vs TransMedics Group Inc — how do they compare? SiTime Corporation trades at $700.42 (market cap $20.05B), while TransMedics Group Inc trades at $87.29 (market cap $3.10B). The key difference: SiTime Corporation is far larger — about 6.5× TransMedics Group Inc's market cap, and SiTime Corporation is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals.
| SITM | TMDX | |
|---|---|---|
Market Cap | $20.05B | $3.10B |
Sector | Technology | Technology |
52-Week High | $901.60 | $150.42 |
52-Week Low | $212.77 | $61.99 |
Enterprise Value | $19.45B | $3.49B |
Signals from Pluang's Aura AI — not financial advice
SITM trades at $700.42, up 1.52% today, with a bullish technical outlook and strong analyst consensus. Recent Q2 2026 earnings beat estimates with EPS of $2.34 versus $1.95 expected, driven by 127% revenue growth from AI infrastructure demand. The stock shows robust institutional interest and positive media coverage highlighting AI timing growth.
Outlook is positive with a consensus price target of $870, but risks include high valuation multiples (P/E 1,111.15, P/S 38.1) and integration challenges from the Renesas acquisition. Earnings momentum and AI exposure support upside, yet execution and premium pricing warrant caution for investors.
TransMedics Group (TMDX) trades at $87.42, down 1.12% on the day, with a bullish technical outlook from moving averages but bearish oscillators signaling potential overbought conditions. The company reported mixed Q2 2026 results, missing earnings estimates with EPS of $0.44 versus $0.50 expected, while revenue growth remains robust. Recent news highlights an ongoing investigation into fiduciary duties by directors, adding uncertainty.
The stock presents a cautious opportunity with strong analyst support (69% buy ratings) and a consensus price target of $99.57, implying upside, but risks include earnings volatility, margin pressures, and legal scrutiny. Fundamentals show solid profitability with a 22.69% net margin, though valuation multiples like P/E of 23.15 suggest premium pricing relative to historical norms.
Trailing returns across standard periods
SiTime Corporation is a leading provider of MEMS-based silicon timing solutions used in various electronic applications. The company’s products, including oscillators, resonators, and clock ICs, are designed to replace traditional quartz-based timing devices, offering superior performance, reliability, and smaller size in harsh environments. SiTime's solutions are adopted across high-growth markets such as 5G, data centers, industrial IoT, and automotive, positioning the company as a key enabler for next-generation electronic systems.
Read more on SITM →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →